Insights on FDA's controversial approval of Alzheimer's drug
by Patrick Ercolano,Johns Hopkins UniversitySupriya Munshaw. Credit: Johns Hopkins UniversityThe U.S. Food and Drug Administration's recent approval of aducanumab, a treatment for Alzheimer&
Updated on: May 22,2024
8
Insights on FDA's controversial approval of Alzheimer's drug
by Patrick Ercolano,Johns Hopkins UniversitySupriya Munshaw. Credit: Johns Hopkins UniversityThe U.S. Food and Drug Administration's recent approval of aducanumab, a treatment for Alzheimer&
Updated on:May 22,2024
8
